Iodide

Iodide

SCHEMBL9306525

CCCCCCCCCCCCCCOc1ccc(COC(=O)N(Cc2cc[n+](C)cc2)C(=O)c2ccccc2OC)cc1OC.[I-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.40
NR1I2 O75469 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADRA2A P08913 1/20 0.40
OPRK1 P41145 1/20 0.40
HTR2B P41595 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KMT2A Q03164 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL9308460 0.93 LMNA (0.41) LMNAMAPTHTTSMN1; SMN2L3MBTL1
Iodide SCHEMBL9308385 0.93 ATM (0.42) LMNAMAPTMEN1NR1I2CHRM2
Iodide SCHEMBL9306084 0.93 LMNA (0.40) LMNAMAPTHTTSMN1; SMN2L3MBTL1
Iodide SCHEMBL9308315 0.92 LMNA (0.39) LMNAMAPTHTTSMN1; SMN2L3MBTL1
Iodide SCHEMBL9307941 0.91 THRA (0.39) LMNAMAPTMEN1NR1I2CHRM2
Iodide SCHEMBL9307284 0.91 MEN1 (0.39) LMNAMAPTMEN1NR1I2CHRM2
Iodide SCHEMBL9307395 0.91
Iodide SCHEMBL9308919 0.89
Iodide SCHEMBL9308001 0.89 LMNA (0.39) LMNAMAPTHTTSMN1; SMN2L3MBTL1
Iodide SCHEMBL9305492 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5328921-A Antagonist of platelet activating factor AMERICAN CYANAMID COMPANY (US) 1994-07-12 US disclosed